obesity-induced gut microbial metabolite promotes liver cancer senescence secretome
obesity become prevalent developed countries past decades increasingly recognized major risk factor several common types cancer worldwide obesity epidemic shown signs abating better understanding mechanisms underlying obesity-associated cancer urgently needed although several events proposed involved obesity-associated cancer1 exact molecular mechanisms integrate events remained largely unclear show senescence-associated secretory phenotype sasp crucial roles promoting obesity-associated hepatocellular carcinoma hcc development mice dietary genetic obesity induces alterations gut microbiota thereby increasing levels deoxycholic acid dca gut bacterial metabolite known cause dna damage enterohepatic circulation dca provokes sasp phenotype hepatic stellate cells hscs turn secretes various inflammatory tumour-promoting factors liver thus facilitating hcc development mice exposure chemical carcinogen notably blocking dca production reducing gut bacteria efficiently prevents hcc development obese mice similar results also observed mice lacking sasp inducer depleted senescent hscs indicating dca-sasp axis hscs key roles obesity-associated hcc development moreover signs sasp also observed hscs area hcc arising patients non-alcoholic steatohepatitis indicating similar pathway may contribute least certain aspects obesity-associated hcc development humans well findings provide valuable new insights development obesity-associated cancer open new possibilities control
